Zdravko Kamenov
Zdravko Kamenov is an expert in Endocrinology at Alexandrovska Hospital (Bulgaria). As of October 2026, ScienceLeadR ranks Zdravko Kamenov in the top 1% of experts worldwide for Glucose Metabolism Disorders, and in the top 1% of experts in Bulgaria for Insulin Resistance and Hyperinsulinism. Zdravko Kamenov has authored 168 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 2 of them ongoing. SLR score: 758 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Nutrition - Gynecology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 168
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study). PMID 42719233 — diabetes mellitus, safety, incidence, therapeutics, hypoglycemia, metformin, diabetes mellitus, type 2, single-pill combination | Front Clin Diabetes Healthc | 2026 | 0 |
| Role of Alpha-Defensins 3 and 5 in Diabetic Complications: Associations with Nephropathy and Metabolic Parameters in Type 2 Diabetes. PMID 42646306 — diabetes mellitus, creatinine, peripheral nervous system diseases, serum, diabetic nephropathies, alpha-defensins, neutrophils, cholesterol, defensins, immunity, innate, carbohydrates, diabetes complications, diabetes mellitus, type 2 | Metabolites | 2026 | 0 |
| GPIHBP1 as a Biomarker of Diabetic Polyneuropathy and Vascular Complications in Type 2 Diabetes Mellitus. PMID 42194055 — diabetes mellitus, biomarkers, diabetic neuropathies, polyneuropathies, obesity, diabetes mellitus, type 2 | Biomolecules | 2026 | 0 |
| Angiopoietin-like Proteins 4 and 8 in Diabetic Complications: Associations with Neuropathy and Metabolic Parameters in Type 2 Diabetes. PMID 42194593 — diabetes mellitus, peripheral nervous system diseases, serum, angiopoietin-like proteins, angiopoietins, diabetes complications, diabetes mellitus, type 2 | J Clin Med | 2026 | 0 |
| Corneal Confocal Microscopy as a Non-Invasive Marker of Small Fiber Neuropathy and Systemic Complications in Type 2 Diabetes: A Cross-Sectional Study. PMID 42072606 — diabetes mellitus, microscopy, confocal, cross-sectional studies, peripheral nervous system diseases, nerve fibers, microscopy, small fiber neuropathy, diabetes mellitus, type 2 | Biomolecules | 2026 | 0 |
Clinical Studies 14
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Long Term Extension Study of IMVT 1402 in Adult Patients With Graves Disease 2025-524001-33-00 — safety, graves disease | Phase 2 | Recruiting | 2026 |
| AMAZE 12 A research study investigating how well the medicine NNC0487 0111 helps people with excess body weight maintain their weight loss 2025-523804-62-00 — safety, body weight, obesity, research, weight loss | Phase 3 | Recruiting | 2026 |
LeadR Networks
Main global connection map